Home · Open Lab · Lot RGX-26-RGNX-732
RGX-26-RGNX-732Superseded
Epitalon · 10 MG · Longevity Research · COA NS-2026-05211

Release test results

99.721%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.04 mg
Related impurities (total)0.279%
Endotoxin<1.0 EU/mg
HPLC retention time8.11 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundEpitalon
Presentation10 MG
Lot numberRGX-26-RGNX-732
COA numberNS-2026-05211
Test date02 Sep 2026
Release date05 Sep 2026
Independent labNordicstar Labs
StatusSuperseded

Epitalon — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-RGNX-106810 MGSep 8, 202699.654%Current
RGX-26-RGNX-63210 MGSep 7, 202699.683%Superseded
RGX-26-RGNX-73150 MGSep 5, 202699.645%Superseded
RGX-26-RGNX-63150 MGSep 5, 202699.690%Superseded
RGX-26-RGNX-106950 MGSep 2, 202699.576%Current
RGX-26-RGNX-732 this lot10 MGSep 2, 202699.721%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →